01 Increasing Adoption of Advanced Mass Spectrometry for Metabolite Profiling The metabolomics market is witnessing growing adoption of high-resolution mass spectrometry, advanced chromatography, and improved data-analysis tools to identify and quantify metabolites with greater sensitivity and accuracy. These technologies are supporting applications in biomarker discovery, drug development, disease research, and personalized medicine. Improvements in data processing are also helping researchers analyze complex untargeted metabolomics datasets more efficiently. For instance, in May 2025, Bruker launched its timsMetabo mass spectrometer for 4D metabolomics and lipidomics, focusing on improved sensitivity, specificity, annotation confidence, and analytical depth.
02 Growing Focus on Single-Cell Metabolomics and AI-Based Data Analysis The metabolomics market is increasingly moving toward single-cell analysis and computational approaches that can reveal metabolic differences between individual cells. This trend is expanding the use of metabolomics in cancer research, aging studies, and precision medicine. For instance, in February 2026, researchers reported a high-throughput single-cell metabolomics platform that detected more than 5,000 metabolic peaks and approximately 800 metabolites per cell, demonstrating major improvements in metabolite coverage and sensitivity.
June 2026 Bruker Corporation acquired biocrates life sciences AG, expanding its metabolomics portfolio with standardized metabolite assays and advanced biomarker discovery solutions.
March 2026 Agilent Technologies launched the InfinityLab Pro iQ Series LC/MS systems, enhancing high-sensitivity metabolomics workflows for clinical research and life sciences applications.
October 2025 Revvity expanded its collaboration with Genomics England to integrate metabolomics into multi-omics research, supporting biomarker discovery and precision medicine initiatives.
June 2025 Thermo Fisher Scientific launched the Orbitrap Astral Zoom Mass Spectrometer, strengthening high-throughput metabolomics and multi-omics research capabilities.